These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series. Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, Cunico SC, Longo N, Martignoni G, Minervini A, Mirone V, Simonato A, Terrone C, Zattoni F, Ficarra V, Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project, Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation. BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519 [Abstract] [Full Text] [Related]
3. The influence of the primary tumor on the long-term results of pulmonary metastasectomy for metastatic renal cell carcinoma. Bölükbas S, Kudelin N, Eberlein M, Fisseler-Eckhoff A, Schirren J. Thorac Cardiovasc Surg; 2012 Sep; 60(6):390-7. PubMed ID: 22207364 [Abstract] [Full Text] [Related]
12. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus. Kim KH, You D, Jeong IG, Kwon TW, Cho YM, Hong JH, Ahn H, Kim CS. BJU Int; 2012 Dec; 110(11 Pt B):E673-8. PubMed ID: 22973869 [Abstract] [Full Text] [Related]